Stimdia Medical announced today that it received FDA breakthrough device designation for its pdSTIM system. Minneapolis-based Stimdia’s pdSTIM system is designed to offer a tool in addressing high-risk patients, including those with COVID-19, by providing a minimally invasive neurostimulation solution to awaken and recondition the diaphragm, according to a news release. The platform facilitates the […]
